Spinal TRPC3 promotes neuropathic pain and coordinates phospholipase C–induced mechanical hypersensitivity

S Shota Tobori (Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University) K Kosei Tamada (Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University) N Nagi Uemura (Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University) K Kyoko Sawada (Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University) M Masashi Kakae (Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University) K Kazuki Nagayasu (Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University) T Takayuki Nakagawa (Department of Clinical Pharmacology and Pharmacotherapy, School of Pharmaceutical Sciences, Wakayama Medical University) Y Yasuo Mori S Shuji Kaneko (Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University) H Hisashi Shirakawa (Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University)

Abstract

Neuropathic pain is a debilitating chronic condition mainly caused by peripheral nerve injury. However, the cellular and molecular mechanisms underlying this condition remain unclear. Transient receptor potential canonical 3 (TRPC3), a TRP channel that is activated by downstream of the Gq-phospholipase C (PLC) axis, is expressed in the somatosensory system. Therefore, the present study investigated its pathophysiological role in neuropathic pain following peripheral nerve injury. Here, partial sciatic nerve ligation (pSNL) elicited mechanical and thermal hypersensitivity in wild-type mice, which was suppressed in TRPC3-KO mice. In situ hybridization revealed that TRPC3 is predominantly expressed in neurons in the spinal dorsal horn. Furthermore, spinal dorsal horn neuron-specific downregulation using miRNA attenuated pSNL-induced mechanical hypersensitivity. Spinal TRPC3 activation elicited acute mechanical hypersensitivity. Moreover, its genetic ablation reduced the mechanical hypersensitivity caused by spinal NK 1 R or PLC activation. These findings demonstrate that TRPC3 in spinal dorsal horn neurons facilitates the development of neuropathic pain. Therefore, TRPC3 may be a promising therapeutic target for neuropathic pain caused by peripheral nerve injury.

Article Details

Volume / Issue Vol. 122, Issue 11
Published March 18, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (10)

S

Shota Tobori

Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University

K

Kosei Tamada

Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University

N

Nagi Uemura

Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University

K

Kyoko Sawada

Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University

M

Masashi Kakae

Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University

K

Kazuki Nagayasu

Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University

T

Takayuki Nakagawa

Department of Clinical Pharmacology and Pharmacotherapy, School of Pharmaceutical Sciences, Wakayama Medical University

Y

Yasuo Mori

S

Shuji Kaneko

Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University

H

Hisashi Shirakawa

Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University